Are you a new member? Sign up now
Login area
| Sign up
close
APO-ROSUVASTATIN - 20mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 7497 | 186100/13 | APO-ROSUVASTATIN | 20mg | 30 | Tablet | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 670,577 L.L | 23.08 | A1 | Apotex Inc | Canada | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C10AA07 | B | Rosuvastatin (calcium) - 20mg | 1712 | 195491/04 | CRESTOR | 20mg | 28 | Tablet, film coated | Oral | Omnipharma | IPR Pharmaceuticals | USA | 804,962 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 7862 | 186192/13 | CRESOTAB | 20mg | 30 | Tablet, film coated | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 517,379 L.L | 23.08 | A1 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 6343 | 168139/10 | CRESULIP 20 | 20mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 575,933 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 9610 | 87418/1 | LIPIROSE OBP 20 | 20mg | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 639,925 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 8874 | 186624/13 | PMS-ROSUVASTATIN | 20mg | 30 | Tablet | Oral | UPO S.A.L. | Pharmascience Inc | Canada | 564,414 L.L | 23.08 | A1 | Pharmascience Inc | Canada | 2/5/2024 | 0 |
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 8119 | 36815/1 | PREVAST 20-IPS | 20mg | 30 | Tablet, film coated | Oral | IPS "Integrated Pharma Solutions SARL" | Benta SAL | Lebanon | 639,925 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 6303 | 167997/11 | ROSUCOR | 20mg | 30 | Tablet, film coated | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 487,623 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 11347 | FE15323/1 | ROSUPHAR | 20mg | 30 | Tablet, film coated | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 487,623 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 5485 | 195051/04 | ROSUVAS | 20mg | 30 | Tablet, film coated | Oral | Mediterranean Pharmaceutical Company | Sun Pharmaceuticals Industries Ltd | India | 450,187 L.L | 23.08 | A1 | Sun Pharmaceuticals Industries Ltd | India | 2/5/2024 | 0 |
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 7384 | 167709/10 | ROVASTIN | 20mg | 30 | Tablet | Oral | Pharmapro | Mediphar Laboratories | Lebanon | 812,705 L.L | 23.08 | A2 | 2/5/2024 | 0 | ||
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 7768 | 186813/14 | ROXARDIO | 20mg | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Pharmaline under license from Sandoz GmbH, Austria | Lebanon | 699,405 L.L | 23.08 | A1 | Lek Pharmaceuticals dd, Slovenia (raw material) | 2/5/2024 | 0 | |
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 4094 | 24357/06 | SINLIP | 20mg | 30 | Tablet, film coated | Oral | Droguerie Phenicia | Gador SA | Argentine | 563,070 L.L | 23.08 | A1 | Gador SA | Argentine | 2/5/2024 | 0 |
| C10AA07 | G | Rosuvastatin (calcium) - 20mg | 7037 | 96884/12 | SUPERSTAT | 20mg | 30 | Tablet, coated | Oral | Abela Frères S.A.L. | Ibn Al Baytar | Tunisia | 517,379 L.L | 23.08 | A1 | Ibn Al Baytar | Tunisia | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024